查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679398

失智症治疗市场规模、份额、趋势分析报告：按适应症、药物类别、给药途径、分销管道、地区、细分预测，2025-2030 年

Dementia Treatment Market Size, Share & Trends Analysis Report By Indication, By Drug Class, By Route Of Administration (Oral, Transdermal Patch, Injectable), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

失智症治疗市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球失智症治疗市场预计到 2030 年将达到 281.1 亿美元，2025 年至 2030 年期间的复合年增长率为 8.0%。

失智症患者数量的增加、新药的推出以及市场相关人员和研究机构日益参与开发有效的治疗方法是推动市场成长的一些主要因素。根据Cross River Therapy 2023年9月发布的资料，英国阿兹海默症（AD）的盛行率约为每十万人42.70例，是人均盛行率第二高的国家。

政府和非政府组织采取越来越多的有利倡议来支持失智症治疗的宣传宣传活动和开发新治疗方法的研究活动，预计将推动市场成长。例如，2022年2月，麦吉尔大学的失智症教育计画获得加拿大公共卫生署的资助，启动了15个计划，以提高人们对该疾病的认识。失智症社区投资 (DCI) 将提供 758,430 美元，用于支持该学院为期十週的成人学习者十个线上模组 (TOTAL)数位学习，并提高看护者的意识。

学术研究机构也从事研究活动，例如研究不同类型的失智症以及开发有效的治疗方法以减轻整体疾病负担。例如，2024年2月，科罗拉多大学安舒兹医学院的研究人员发现，Mdm2蛋白和在临床实验抗癌药物nutlin可以防止与阿兹海默症相关的突触和树突棘的破坏。此外，2023 年 12 月，宾州大学佩雷尔曼医学院的临床前研究表明，Chaperone分子与特定蛋白质结合可以逆转大脑老化和疾病的征兆，包括记忆力丧失。

市场先驱正在与当地参与企业和研究机构合作，以提高他们开发有效、安全的失智症治疗方法的能力。 2021 年 2 月，Exscientia 与牛津大学合作开发阿兹海默症的治疗方法。此外，卫材株式会社和 Biogen 已展开合作，以加速开发治疗方法失智症的有效方法。两家公司共同开发了aducanumab和lecanemab。两家公司均已获得全球主要监管机构对这些药物的市场核准。

失智症治疗市场报告重点

  • 由于AD失智症盛行率高，且认证核可药数量众多，到2024年其在适应症细分市场中占据主导地位，份额达59.8%。
  • 由于发病率和严重程度不断增加，路易氏体失智症(LBD) 领域预计将在 2025 年至 2030 年间以最快的复合年增长率成长。
  • 胆碱酯酶抑制剂领域在 2024 年占据最大份额，这得益于其较高的口服和经皮吸收贴片组合。
  • 由于组合药物的有效性和采用率不断提高，预计组合药物领域将在 2025 年至 2030 年间以最快的复合年增长率增长。
  • 由于生技药品的引入和有前景的注射剂的出现，预计注射剂领域将在 2025 年至 2030 年间实现最快的复合年增长率。
  • 2024 年，北美将主导全球市场，原因包括该地区疾病盛行率高、市场参与企业强大以及报销政策更好等因素。

目录

第一章调查方法与范围

第二章执行摘要

第三章失智症治疗市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析

第四章失智症治疗市场：适应症业务分析

  • 2024年及2030年的指示市场占有率
  • 指示细分仪表板
  • 2018 年至 2030 年市场规模、预测与趋势分析（按适应症）
  • 阿兹海默症失智症
  • 血管性失智症
  • 路易氏体失智症
  • 额颞叶型失智症（FTD）
  • 帕金森氏症失智症
  • 其他的

第五章失智症治疗市场：药物类业务分析

  • 2024 年及 2030 年药品类别市场占有率
  • 药品类别细分仪表板
  • 2018 年至 2030 年药品类别市场规模、预测与趋势分析
  • 胆碱酯酶抑制剂
  • NMDA受体拮抗剂
  • MAO抑制剂
  • 伴随用药
  • 其他的

第六章失智症治疗市场：给药途径业务分析

  • 2024 年及 2030 年给药途径市场占有率
  • 给药途径细分仪表板
  • 2018 年至 2030 年按给药途径分類的市场规模、预测和趋势分析
  • 口服
  • 经皮吸收贴片
  • 注射

第七章失智症治疗市场：通路业务分析

  • 2024年及2030年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018 年至 2030 年分销通路市场规模、预测与趋势分析
  • 医院药房
  • 零售药局
  • 网路药局

第八章失智症治疗市场：区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Novartis AG
    • DAIICHI SANKYO COMPANY, LIMITED
    • AbbVie Inc.
    • Lundbeck
    • Biogen
    • Cipla
    • Sun Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: GVR-4-68040-258-5

Dementia Treatment Market Growth & Trends:

The global dementia treatment market size is anticipated to reach USD 28.11 billion by 2030, registering a CAGR of 8.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing patient base of dementia, introduction of novel drugs, and increasing involvement of market players and research institutes to develop effective treatment for the disease are some of key factors driving market growth. According to the Cross River Therapy data published in September 2023, the prevalence of Alzheimer's disease (AD) in the UK is around 42.70 cases per 100,000 people, which makes it the country with the second-greatest number of cases per capita.

Increasing favorable initiatives undertaken by government and non-government bodies to support the awareness campaign and research activities to develop novel therapies for dementia treatment are anticipated to fuel market growth. For instance, in February 2022, McGill University's Dementia Education Program initiated 15 projects funded by the Public Health Agency of Canada to increase awareness about the disease. The Dementia Community Investment (DCI) is going to invest USD 758,430 to support the University's Ten Online Modules over Ten Weeks for Adult Learners (TOTAL) eLearning to spread awareness among caregivers.

Academic and research institutes are further involved in research activities to study different types of dementia and development of effective therapeutics to reduce the overall disease burden. For instance, in February 2024, researchers at the University of Colorado Anschutz Medical Campus found that Mdm2 protein with an investigational cancer drug, nutlin, can prevent the destruction of synapses and dendritic spines associated with Alzheimer's disease. Moreover, in December 2023, A preclinical study from the Perelman School of Medicine at the University of Pennsylvania showed that a chaperone molecule formulated specific proteins that can reverse disease signs including aging brain and memory impairment.

Market players are collaborating with regional players and research institutions to increase their capabilities to develop effective and safe therapy for dementia. In February 2021, Exscientia and the University of Oxford tied up to develop therapies for Alzheimer's disease. Moreover, Eisai Co., Ltd. and Biogen partnered to develop effective therapies for dementia earlier. These companies have jointly developed aducanumab and lecanemab. The companies are receiving market approvals for these drugs from key regulatory authorities across the globe.

Dementia Treatment Market Report Highlights:

  • The AD dementia segment dominated the indication segment market with a share of 59.8% in 2024 owing to a high prevalence of AD dementia and approved drugs
  • The Lewy body dementia (LBD) segment is expected to grow at the fastest CAGR from 2025 to 2030 owing to the increasing incidence and severity of the disease
  • The cholinesterase inhibitors segment held the largest share in 2024 owing to high prescription rate of oral and transdermal patches of these drugs
  • The combination drug segment is projected to experience the fastest CAGR from 2025 to 2030 owing to increased effectiveness and adoption of combination drugs
  • The injectables route of administration segment is anticipated to register the fastest CAGR from 2025 to 2030 owing to the introduction of biological drugs and the presence of promising injectable drugs in the pipeline
  • North America dominated the global market in 2024 owing to factors, such as high disease prevalence, presence of strong market players, and better reimbursement policies in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. Drug Class
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Dementia Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Dementia Treatment Market: Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Alzheimer's Disease Dementia
    • 4.4.1. Alzheimer's Disease Dementia Market, 2018 - 2030 (USD Million)
  • 4.5. Vascular Dementia
    • 4.5.1. Vascular Dementia Market, 2018 - 2030 (USD Million)
  • 4.6. Lewy Body Dementia
    • 4.6.1. Lewy Body Dementia Market, 2018 - 2030 (USD Million)
  • 4.7. Frontotemporal Dementia (FTD)
    • 4.7.1. Frontotemporal Dementia (FTD) Market, 2018 - 2030 (USD Million)
  • 4.8. Parkinson Disease Dementia
    • 4.8.1. Parkinson Disease Dementia Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Dementia Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2030
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 5.4. Cholinesterase Inhibitors
    • 5.4.1. Cholinesterase Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.5. NMDA Receptor Antagonist
    • 5.5.1. NMDA Receptor Antagonist Market, 2018 - 2030 (USD Million)
  • 5.6. MAO Inhibitors
    • 5.6.1. MAO Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.7. Combination Drugs
    • 5.7.1. Combination Drugs Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Dementia Treatment Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market, 2018 - 2030 (USD Million)
  • 6.5. Transdermal Patch
    • 6.5.1. Transdermal Patch Market, 2018 - 2030 (USD Million)
  • 6.6. Injectable
    • 6.6.1. Injectable Market, 2018 - 2030 (USD Million)

Chapter 7. Dementia Treatment Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Dementia Treatment Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Eisai Co., Ltd.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Eli Lilly and Company
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Novartis AG
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. DAIICHI SANKYO COMPANY, LIMITED
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. AbbVie Inc.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Lundbeck
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Biogen
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Cipla
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Sun Pharmaceutical Industries Ltd.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Viatris Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global dementia treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 5. Global dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 6. Global dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 7. Global dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8. North America dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 9. North America dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 10. North America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 11. North America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12. North America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13. U.S. dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 14. U.S. dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 15. U.S. dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 16. U.S. Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17. Canada dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 18. Canada dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 19. Canada dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 20. Canada dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21. Mexico dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 22. Mexico dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 23. Mexico dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 24. Mexico dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25. Europe dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 26. Europe dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 27. Europe dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 28. Europe dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 29. Europe dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30. UK dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 31. UK dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 32. UK dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 33. UK Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34. Germany dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 35. Germany dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 36. Germany dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37. Germany dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38. France dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 39. France dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 40. France dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 41. France Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42. Italy dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 43. Italy dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 44. Italy dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 45. Italy dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46. Spain dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 47. Spain dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 48. Spain dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 49. Spain dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50. Norway dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Norway dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 52. Norway dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 53. Norway Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54. Denmark dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 55. Denmark dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 56. Denmark dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 57. Denmark dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58. Sweden dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 59. Sweden dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 60. Sweden dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 61. Sweden dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67. Japan dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 68. Japan dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 69. Japan dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 70. Japan dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71. China dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 72. China dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 73. China dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 74. China dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75. India dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 76. India dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 77. India dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78. India dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79. Australia dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 80. Australia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 81. Australia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82. Australia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83. South Korea dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 84. South Korea dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 85. South Korea dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 86. South Korea dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87. Thailand dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 88. Thailand dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 89. Thailand dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 90. Thailand dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 91. Latin America dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 92. Latin America dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 93. Latin America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 94. Latin America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 95. Latin America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96. Brazil dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 97. Brazil dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 98. Brazil dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 99. Brazil dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 100. Argentina dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 101. Argentina dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 102. Argentina dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 103. Argentina dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 109. South Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 110. South Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 111. South Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 112. South Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117. UAE dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 118. UAE dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 119. UAE dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 120. UAE dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 121. Kuwait dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 122. Kuwait dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 123. Kuwait dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 124. Kuwait dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Dementia treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Indication and drug class outlook (USD Million)
  • Fig. 10 Route of administration and distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Dementia treatment market dynamics
  • Fig. 13 Dementia treatment market: Porter's five forces analysis
  • Fig. 14 Dementia treatment market: PESTLE analysis
  • Fig. 15 Dementia treatment market: Indication segment dashboard
  • Fig. 16 Dementia treatment market: Indication market share analysis, 2024 & 2030
  • Fig. 17 Alzheimer's disease dementia market, 2018 - 2030 (USD Million)
  • Fig. 18 Vascular dementia market, 2018 - 2030 (USD Million)
  • Fig. 19 Lewy body dementia market, 2018 - 2030 (USD Million)
  • Fig. 20 Frontotemporal dementia (FTD) market, 2018 - 2030 (USD Million)
  • Fig. 21 Parkinson disease dementia market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Dementia treatment market: Drug class segment dashboard
  • Fig. 24 Dementia treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 25 Cholinesterase inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 26 NMDA receptor antagonist market, 2018 - 2030 (USD Million)
  • Fig. 27 MAO inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 28 Combination drugs market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Dementia treatment market: Route of administration segment dashboard
  • Fig. 31 Dementia treatment market: Route of administration market share analysis, 2024 & 2030
  • Fig. 32 Oral market, 2018 - 2030 (USD Million)
  • Fig. 33 Transdermal patch market, 2018 - 2030 (USD Million)
  • Fig. 34 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 35 Dementia treatment market: Distribution channel segment dashboard
  • Fig. 36 Dementia treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 37 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 38 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 39 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 40 Dementia treatment market revenue, by region
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. country dynamics
  • Fig. 45 U.S. dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Canada country dynamics
  • Fig. 47 Canada dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico country dynamics
  • Fig. 49 Mexico dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Europe dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 UK country dynamics
  • Fig. 52 UK dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany country dynamics
  • Fig. 54 Germany dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 France country dynamics
  • Fig. 56 France dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 Italy country dynamics
  • Fig. 58 Italy dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain country dynamics
  • Fig. 60 Spain dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Norway country dynamics
  • Fig. 62 Norway dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden country dynamics
  • Fig. 64 Sweden dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark country dynamics
  • Fig. 66 Denmark dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Japan country dynamics
  • Fig. 69 Japan dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 China country dynamics
  • Fig. 71 China dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 India country dynamics
  • Fig. 73 India dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Australia country dynamics
  • Fig. 75 Australia dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea country dynamics
  • Fig. 77 South Korea dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand country dynamics
  • Fig. 79 Thailand dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil country dynamics
  • Fig. 82 Brazil dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 83 Argentina country dynamics
  • Fig. 84 Argentina dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 85 MEA dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa country dynamics
  • Fig. 87 South Africa dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia country dynamics
  • Fig. 89 Saudi Arabia dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 90 UAE country dynamics
  • Fig. 91 UAE dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait country dynamics
  • Fig. 93 Kuwait dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 94 Company categorization
  • Fig. 95 Company market position analysis
  • Fig. 96 Strategic framework